Bone marrow transplant guided by big data analytics.
Our end of the year message
#bigdataforbloodcancer blog: The importance of patient
HARMONY Multiple Myeloma Experts presenting at EMN2022
IHI publishes about HARMONY AML Research Result
Milestones made in blood cancer research in 2021.
PRESS RELEASE: New AML and CLL research results from HARMONY ...
Over 140 valued HARMONY Alliance community members joined
HARMONY participates in IMI Impact on Patient Involvement event ...
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands